Status and phase
Conditions
Treatments
About
This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
225 participants in 3 patient groups
Loading...
Central trial contact
Reference Study ID Number: GR44278 https://forpatients.roche.com/
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal